- KNSA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
SC 13D Filing
Kiniksa Pharmaceuticals (KNSA) SC 13DKiniksa Pharmaceuticals, Ltd.
Filed: 31 May 18, 4:14pm
Exhibit 99.1
JOINT FILING AGREEMENT
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the beneficial ownership by each of the undersigned of securities of Kiniksa Pharmaceuticals, Ltd.
This Agreement may be executed in any number of counterparts, each of which shall be deemed an original.
EXECUTED as of this 31st day of May 2018
BAKER BROS. ADVISORS LP | ||
By: | Baker Bros. Advisors (GP) LLC, its general partner | |
By: | /s/ Scott L. Lessing | |
Name: Scott L. Lessing Title: President | ||
BAKER BROS. ADVISORS (GP) LLC | ||
By: | /s/ Scott L. Lessing | |
Name: Scott L. Lessing Title: President | ||
/s/ Julian C. Baker | ||
Julian C. Baker | ||
/s/ Felix J. Baker | ||
Felix J. Baker |